Microbial Fermentation Technology Market Trends

  • Report ID: 5329
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Microbial Fermentation Technology Market Trends

Growth Drivers

  • Rising Need for Fermented Food – Fermentation of food is done by regulating microbial development, which involves microorganisms such as yeast and bacteria enzymatically breaking down carbohydrates to produce carbon dioxide, organic acids, or alcohol, and the process also contributes to food sustainability by preserving, securing, and producing food components.
  • Increasing Popularity of CRISPR-Cas9 Technology- CRISPR-Cas9 technology transforms bacteria to boost target product yield and is capable of expanding the range of compounds and products available through fermentation.
  • Growing Adoption of Artificial Intelligence and Machine Learning- AI technology is extremely significant in the development of precision fermentation which is based on the use of microbes – mainly yeasts and fungi and may also assist in developing unique food products that meet the growing customer demand for natural, functional, and sustainable food options.

Additionally, Artificial intelligence is now being utilized to control fermentation operations in real time, and it can analyze past data to forecast future outcomes.

  • Spiking Cases of Infectious Diseases- This may lead to higher production of vaccines and antiviral drugs which are produced using microbial fermentation technology.
  • Rising Need for Gasoline- This has led to an increase in the production of biofuels such as ethanol and butanol which are produced by microbial fermentation that converts sugars derived from lignocellulosic biomass.
  • Growing Production of Biosimilars- Biosimilars are produced using are produced by living cells such as bacteria or yeast and are often produced by advanced fermentation technology.
  • Higher Usage of Single-Use Bioreactor Systems- Single-use bioreactor Systems (SUB Disposable) can be used for microbial fermentation as they reduce the risk of cross-contamination which helps in meeting the stringent regulations of the pharmaceutical industry.

Challenges

  • High Cost of Microbial Fermentation Technology – The research & development for developing a new fermentation process involves a huge cost as it requires skilled labor, high-quality raw materials, and energy-intensive equipment. This may make it difficult for pharmaceutical companies with limited budgets to carry out these processes. Furthermore, setting up a fermentation plant, which includes the cost of labor and other costs incurred to maintain the facility, can easily cost tens to hundreds of millions of dollars.
  • Stringent Regularity Requirements for Biopharmaceutical Production
  • Risk of Microbial Contamination Leading to Product Loss

Microbial Fermentation Technology Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

5.9%

Base Year Market Size (2024)

USD 34.92 billion

Forecast Year Market Size (2037)

USD 73.57 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5329
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of microbial fermentation technology is assessed at USD 36.57 billion.

The microbial fermentation technology market size was valued at USD 34.92 billion in 2024 and is set to reach USD 73.57 billion by the end of 2037, registering around 5.9% CAGR during the forecast period i.e., between 2025-2037. The rising need for vaccines and the growing need for microbial contract manufacturing services will drive the market growth.

Asia Pacific industry is set to dominate majority revenue share 42% by 2037, impelled by presence of the developed chemical sector in the region.

The major players in the market are BioVectra Inc., Danone UK, F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza, Novozymes A/S, TerraVia Holdings, Inc., BIOZEEN
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample